The global antibacterial drugs market size was valued at US$ 43,791.2 million in 2017 and is expected to exhibit a CAGR of 1.4% over the forecast period (2020 – 2027).

Antibacterial Drugs Market - Global Forecast to 2026, by Drug class (Beta lactams, Quinolones, Macrolides, Tetracycline, Aminoglycoside, Sulfonamide, Phenicols, and Others), by Route of Administration (Oral, Topical, Parenteral, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Antibacterial drugs are primarily used in the treatment and prevention of infectious diseases. Antibacterial drugs function by destroying or inhibiting microbial growth in the body.

Growing incidences of infectious diseases are projected to propel the growth of the antibacterial drugs market

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/antibacterial-drugs-market-177

Antibacterial drugs are used in the treatment of infection caused by various bacteria such as Escherichia coli, Klebsiella pneumonia, and others. Moreover, growing incidences of infectious diseases such as tuberculosis, hepatitis B, leprosy, typhoid, malaria, HIV/AIDS and others are projected to fuel the market growth. According to the World Health Organization (WHO) November 2018 factsheet, an estimated 219 million people were diagnosed by malaria in 2017, in 19 countries.

Moreover, rising initiatives by government subjected to a growing number of infectious disease around the globe is expected to propel market growth over the forecast period. For instance, in May 2018, the UK government announced a fund of US$ 34 million to fight against antimicrobial resistance (AMR). This funding will be distributed to the 4 projects such as Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator of US$ 23 million, Global Antibiotic Research and Development Partnership invested US$ 1 million, and US$ 5 million for two projects such as a bilateral partnership with Argentina and Foundation for Innovative New Diagnostics.

Increasing population base rate and high incidences of infectious diseases in North America are projected to foster regional market growth

To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/177

North America holds a dominant position in the global antibacterial drugs market, and this can be attributed to the rising population base susceptible to infectious diseases and high incidences of infectious diseases such as tuberculosis and others. According to the Centers for Disease Control and Prevention (CDC), in 2017, an estimated 9,105 patients were diagnosed with tuberculosis in the U.S.

Moreover, an increasing number of drug approval by the U.S. Food and Drug Administration (FDA) is also expected to boost market growth. For instance, in February 2019, Novartis received the U.S. Food and Drug Administration (FDA) approval for Egaten, used for the treatment of Fascioliasis caused by Fasciola hepatica infection.

Key Players
Major players operating in the global antibacterial drugs market include Novartis AG, Allergan, Bristol Myers Squibb Company, AstraZeneca, Johnson and Johnson, Merck & Co., Inc., GlaxoSmithKline Plc. (GSK), Sanofi SA, Bayer AG.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/177

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737